181
Views
1
CrossRef citations to date
0
Altmetric
Gestational diabetes

Apelin levels in pregnant women with and without gestational diabetes mellitus: a collaborative systematic review and meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 803-812 | Received 15 May 2022, Accepted 12 Aug 2022, Published online: 24 Aug 2022

References

  • Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta. 2001;1538(2-3):162–171.
  • Dawid M, Mlyczyńska E, Jurek M, et al. Apelin, APJ, and ELABELA: Role in placental function, pregnancy, and foetal development. An overview. Cells. 2021;11(1):99.
  • Li L, Yang G, Li Q, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006;114(10):544–548.
  • Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg. 2009;19(11):1574–1580.
  • Cavallo MG, Sentinelli F, Barchetta I, et al. Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus. PLoS One. 2012;7(12):e51236.
  • Tasci I, Dogru T, Naharci I, et al. Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes. 2007;115(7):428–432.
  • Bao W, Baecker A, Song Y, et al. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. Metabolism. 2015;64(6):756–764.
  • Szlapinski SK, Hill DJ. Metabolic adaptations to pregnancy in healthy and gestational diabetic pregnancies: the pancreas-placenta axis. Curr Vasc Pharmacol. 2021;19(2):141–153.
  • Zheng XD, Huang Y, Li H. Regulatory role of apelin-13-mediated PI3K/AKT signaling pathway in the glucose and lipid metabolism of mouse with gestational diabetes mellitus. Immunobiology. 2021;226(5):152135.
  • Akinci B, Celtik A, Tunali S, et al. Circulating apelin levels are associated with cardiometabolic risk factors in women with previous gestational diabetes. Arch Gynecol Obstet. 2014;289(4):787–793.
  • Kourtis A, Gkiomisi A, Mouzaki M, et al. Apelin levels in normal pregnancy. Clin Endocrinol (Oxf). 2011;75(3):367–371.
  • Vaughan OR, Powell TL, Jansson T. Apelin is a novel regulator of human trophoblast amino acid transport. Am J Physiol Endocrinol Metab. 2019;316(5):E810–E816.
  • Dasgupta S, Banerjee U, Mukhopadhyay P, et al. Clinicopathological study and immunohistochemical analysis of expression of annexin A5 and apelin in human placentae of gestational diabetes mellitus. Diabetes Metab Syndr. 2022;16(3):102435.
  • Sun J, Ren J, Zuo C, et al. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and Meta-analysis. Lipids Health Dis. 2020;19(1):26.
  • Noori-Zadeh A, Bakhtiyari S, Khanjari S, et al. Elevated blood apelin levels in type 2 diabetes mellitus: a systematic review and Meta-analysis. Diabetes Res Clin Pract. 2019;148:43–53.
  • Moher D, A. Liberati, J. Tetzlaff, D.G. Altman, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341. Erratum in: Int J Surg. 2010;8:658.
  • Aslan M, Celik O, Celik N, et al. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine. 2012;41(3):424–429.
  • Boyadzhieva M, Atanasova I, Zacharieva S, et al. Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls. J Endocrinol Invest. 2013;36:944–949.
  • Duan E, Zhu X, Zhou S. Study on the change of serum apelin level of patients with gestational diabetes mellitus. Int Med Health Guidance News. 2016;22:2917–2919.
  • Fu Y, Xin Y, Zhang D, et al. Analysis of apelin level and related factors in gestational diabetic patients. Modern Med J China. 2011;13:31–32.
  • Guo YY, Li T, Liu H, et al. Circulating levels of elabela and apelin in the second and third trimesters of pregnancies with gestational diabetes mellitus. Gynecol Endocrinol. 2020;36(10):890–894.
  • Mierzyński R, Poniedziałek-Czajkowska E, Dłuski D, et al. The potential role of chemerin, lipocalin 2, and apelin in the diagnosis and pathophysiology of gestational diabetes mellitus. J Diabetes Res. 2021;2021:5547228.
  • Oncul M, Tuten A, Erman H, et al. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus. Minerva Med. 2013;104(5):527–535.
  • Pan J. Changes of fasting serum apelin-36 and relative factors in patients with gestational diabetes mellitus. Anhui Med J. 2014;6:764–767.
  • Sun R, Zhang NN, Qi Q, et al. Serum apelin level and its influence on gestational diabetes in advanced stages of pregnancy. Chinese General Practice. 2021;24(3):298–303.
  • Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, et al. Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract. 2010;87(2):176–183.
  • Wang X, Xi X. Analysis of plasma apelin level and related factors in patients with gestational diabetes mellitus. Chinese J Clin. 2013;7(13):5920–5922.
  • Zhang C. Analysis of apelin level and related factors in gestational diabetic patients. China Medical Herald. 2012;9(6):49–50.
  • Zhang H, Xie J, Zhang L, et al. Relationship between serum apelin level and insulin resistance in patients with gestational diabetes mellitus. China Practice Med. 2014;9(19):97–98.
  • Zhang J, Liu X, Dong W, et al. Correlation between serum levels of Cys-C and apelin and gestational diabetes mellitus. Chinese J Clin Rational Drug Use. 2015;8(12A):169–170.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
  • Hedges LV. Fitting categorical models to effect sizes from a series of experiments. J Educational Statistics. 1982;7(2):119–137.
  • Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Handbook for Systematic Reviews of Interventions. Chapter 10: Analysing data and undertaking meta-analyses. 2022. https://training.cochrane.org/handbook/current.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple graphical test. BMJ. 1997;315(7109):629–634.
  • ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists no. 30: September 2001 (replaces technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001;98(3):525–538.
  • Metzger BE, Gabbe SG, Persson B, International Association of Diabetes and Pregnancy Study Groups Consensus Panel, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(7):e98.
  • 乐杰.妇产科学.7版, 北京:人民卫生出版社, Le J. Obstetrics and gynecology. 7th ed. Beijing: People’s Health Publishing House; 2008. p. 150–154.
  • Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: A World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103(3):341–363.
  • Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(1):S64–S71.
  • Fruscalzo A, Londero AP, Biasizzo J, et al. Second trimester maternal plasma and amniotic fluid adipokines in women who will develop gestational diabetes mellitus. Gynecol Endocrinol. 2015;31(12):934–938.
  • Francis EC, Li M, Hinkle SN, et al. Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: a longitudinal study in a multiracial cohort. BMJ Open Diab Res Care. 2020;8(1):e001333.
  • Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251(2):471–476.
  • Katugampola SD, Maguire JJ, Matthewson SR, et al. [125I]-(Pyr1) apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol. 2001;132(6):1255–1260.
  • Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764–1771.
  • Sörhede Winzell M, Magnusson C, Ahrén B. The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul Pept. 2005;131(1-3):12–17.
  • Dray C, Knauf C, Daviaud D, et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008;8(5):437–445.
  • Yue P, Jin H, Aillaud M, et al. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298(1):E59–67.
  • Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf). 2012;76(1):2–11.
  • Habchi M, Duvillard L, Cottet V, et al. Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control. Clin Endocrinol. 2014;81(5):696–701.
  • Song L, Wang N, Peng Y, et al. Placental lipid transport and content in response to maternal overweight and gestational diabetes mellitus in human term placenta. Nutr Metab Cardiovasc Dis. 2022;32(3):692–702.
  • Ruiz-Palacios M, Ruiz-Alcaraz AJ, Sanchez-Campillo M, et al. Role of insulin in placental transport of nutrients in gestational diabetes mellitus. Ann Nutr Metab. 2017;70(1):16–25.
  • Castan-Laurell I, Boucher J, Dray C, et al. Apelin, a novel adipokine over-produced in obesity: fried or foe? Mol Cell Endocrinol. 2005;245(1–2):7–9.
  • Bellos I, Fitrou G, Pergialiotis V, et al. Serum levels of adipokines in gestational diabetes: a systematic review. J Endocrinol Invest. 2019;42(6):621–631.
  • Sterne JA, Jüni P, Schulz KF, et al. Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta-epidemiological’ research. Stat Med. 2002;21(11):1513–1524.
  • Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, et al. Circulating apelin concentrations in mother/infant pairs at term. Acta Paediatr. 2007;96(12):1751–1754.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.